2Valles J, Ferrer R. Bloodstream infection in the ICU. Infect Dis Clin North Am ,2009,23:557-569. 被引量：1
3Digiovine B, Chenoweth C, Watts C, et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med, 1999,160:976- 981. 被引量：1
4Warren DK, Quadir WW, Hollenbeak CS, et al. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med,2006,34:2084- 2089. 被引量：1
5Renaud B, Brun-Buisson C, ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and casecontrol study in critically ill patients. Am J Respir Crit Care Med, 2001,163 : 1584-1590. 被引量：1
6Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control, 2008,36:309-332. 被引量：1
7Suljagic V, Cobeljic M, Jankovic S, et al. Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control,2005, 33:333-340. 被引量：1
8Harbarth S, Ferriere K, Hugonnet S, et al. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg, 2002,137 : 1353-1359. 被引量：1
9Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med, 2001,344 : 699 -709. 被引量：1
10Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia:a prospective study of patients not initially admitted to the ICU. Chest,2005,127:1260-1270. 被引量：1
